Metraipolis › archive › dc_d9cb747b61fd
Olanzapine and peripheral metabolic dysregulation: organ-resolved mechanisms, risk, and MASLD-aligned care pathways — Europe PMC PMID:42007333
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42007333
- DOI
- 10.3389/fphar.2025.1729264
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T12:16:03.522Z
- SHA-256 of the archived text
e9ec92a3fc8f5249f7e73913c4ed68bd9181229ba9adf68a341e8aa1a45cf7d9- Stable URL of this page
https://metraipolis.com/documento/dc_d9cb747b61fd
How to cite
Olanzapine and peripheral metabolic dysregulation: organ-resolved mechanisms, risk, and MASLD-aligned care pathways — Europe PMC PMID:42007333 — Europe PMC (en), https://europepmc.org/article/MED/42007333 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d9cb747b61fd (Metraipolis archive dc_d9cb747b61fd, sha256 e9ec92a3fc8f5249f7e73913c4ed68bd9181229ba9adf68a341e8aa1a45cf7d9)
BibTeX
@misc{dcd9cb747b61fd,
title = {Olanzapine and peripheral metabolic dysregulation: organ-resolved mechanisms, risk, and MASLD-aligned care pathways — Europe PMC PMID:42007333},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42007333},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d9cb747b61fd; sha256 e9ec92a3fc8f5249f7e73913c4ed68bd9181229ba9adf68a341e8aa1a45cf7d9},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42007333. Agents can read the archived copy with the MCP tool read_document.